RAPT Therapeutics, Inc.·4

May 13, 5:15 PM ET

Lam Karen C 4

4 · RAPT Therapeutics, Inc. · Filed May 13, 2020

Insider Transaction Report

Form 4
Period: 2020-05-12
Lam Karen C
VP, Finance & Controller
Transactions
  • Exercise/Conversion

    Stock option (right to buy)

    2020-05-122,7775,556 total
    Exercise: $1.86Exp: 2027-09-06Common Stock (2,777 underlying)
  • Exercise/Conversion

    Common Stock

    2020-05-12$1.86/sh+2,777$5,16513,610 total
Footnotes (1)
  • [F1]The option vests in accordance with the following schedule: twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION